LadaTech Sues Illumina Over DNA Analysis Patent
The complaint, filed Friday in the U.S. District Court for the District of Delaware, claims Illumina’s DNA sequencing products, instrumentation and services unlawfully incorporate analytical methods protected by a LadaTech patent.
According to the complaint, Illumina’s system for genetic analysis and DNA sequencing kits infringe U.S. Patent Number 6,107,023, titled “DNA amplification and subtraction techniques.”
“Illumina has been and is still infringing the '023 patent by...
To view the full article, register now.